Literature DB >> 15146455

The androgen receptor gene mutations database (ARDB): 2004 update.

Bruce Gottlieb1, Lenore K Beitel, Jian Hui Wu, Mark Trifiro.   

Abstract

The current version of the androgen receptor (AR) gene mutations database is described. The total number of reported mutations has risen from 374 to 605, and the number of AR-interacting proteins described has increased from 23 to 70, both over the past 3 years. A 3D model of the AR ligand-binding domain (AR LBD) has been added to give a better understanding of gene structure-function relationships. In addition, silent mutations have now been reported in both androgen insensitivity syndrome (AIS) and prostate cancer (CaP) cases. The database also now incorporates information on the exon 1 CAG repeat expansion disease, spinobulbar muscular atrophy (SBMA), as well as CAG repeat length variations associated with risk for female breast, uterine endometrial, colorectal, and prostate cancer, as well as for male infertility. The possible implications of somatic mutations, as opposed to germline mutations, in the development of future locus-specific mutation databases (LSDBs) is discussed. The database is available on the Internet (http://www.mcgill.ca/androgendb/). Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146455     DOI: 10.1002/humu.20044

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  77 in total

Review 1.  Local signalling environments and human male infertility: what we can learn from mouse models.

Authors:  Roopa L Nalam; Martin M Matzuk
Journal:  Expert Rev Mol Med       Date:  2010-05-11       Impact factor: 5.600

2.  "Prostate cancer proteomics" database.

Authors:  S S Shishkin; L I Kovalyov; M A Kovalyova; K V Lisitskaya; L S Eremina; A V Ivanov; E V Gerasimov; E G Sadykhov; N Y Ulasova; O S Sokolova; I Y Toropygin; V O Popov
Journal:  Acta Naturae       Date:  2010-10       Impact factor: 1.845

3.  A canonical cation-π interaction stabilizes the agonist conformation of estrogen-like nuclear receptors.

Authors:  Núria Queralt-Rosinach; Jordi Mestres
Journal:  Eur Biophys J       Date:  2010-04-03       Impact factor: 1.733

4.  Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.

Authors:  Si-Yi Hu; Tao Liu; Zhen-Zhen Liu; Elisa Ledet; Cruz Velasco-Gonzalez; Diptasri M Mandal; Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-02-22       Impact factor: 3.285

5.  Methoxychalcone inhibitors of androgen receptor translocation and function.

Authors:  Yeong Sang Kim; Vineet Kumar; Sunmin Lee; Aki Iwai; Len Neckers; Sanjay V Malhotra; Jane B Trepel
Journal:  Bioorg Med Chem Lett       Date:  2012-01-21       Impact factor: 2.823

6.  An uncommon large deletion in the androgen-receptor gene in a XY female with complete androgen insensitivity syndrome.

Authors:  C Moretti; T Odorisio; R Geremia; P Grimaldi
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

7.  Implication of androgen receptor in urinary bladder cancer: a critical mini review.

Authors:  Arshad H Rahmani; Mohammad Alzohairy; Ali Yousif Y Babiker; Amjad A Khan; Salah M Aly; Moshahid A Rizvi
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

8.  Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H.

Authors:  Dennis J van de Wijngaart; Michel Molier; Scott J Lusher; Remko Hersmus; Guido Jenster; Jan Trapman; Hendrikus J Dubbink
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

9.  Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.

Authors:  Pratap Singh; Gurulingappa Hallur; Ravi K Anchoori; Oladapo Bakare; Yukio Kageyama; Saeed R Khan; John T Isaacs
Journal:  Prostate       Date:  2008-10-01       Impact factor: 4.104

10.  The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer.

Authors:  Andrew P Lieberman; Diane M Robins
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.